Tsighe Abel Zemenfes, Gebreegziabhier Helen Gebremedhin, Sharma Shephali
Nephrology Unit, Department of Internal Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Department of Renal Pathology and TEM, Dr Lal Path Labs Pvt., Ltd, New Delhi, India.
Case Rep Nephrol Dial. 2025 May 9;15(1):125-132. doi: 10.1159/000546060. eCollection 2025 Jan-Dec.
Fibronectin glomerulopathy is a rare autosomal dominant disorder characterized by abnormal deposition of fibronectin within the kidney. It is associated with several variant mutations in the FN1 gene. It is a disorder predominantly characterized by proteinuria that can reach the nephrotic range, and it has been primarily described in Asian and White populations. Here, we report a case of fibronectin glomerulopathy from Ethiopia, which, to our knowledge, is the first ever reported in Africa.
A 17-year-old Ethiopian female presented with generalized body swelling and nephrotic range proteinuria. Secondary causes of nephrotic syndrome were ruled out, but kidney biopsy was not performed early because of financial constraints. The patient received initial treatments with RASi (renin-angiotensin system inhibitor) and diuretics followed by steroids and tacrolimus, but lacked a clear response. Eventually, a kidney biopsy and examination at a pathology laboratory in India revealed extensive periodic acid Schiff-positive but Jones' methenamine silver-negative and Congo red-negative mesangial and capillary wall deposits, which stained strongly for fibronectin on immunohistochemistry. A diagnosis of fibronectin glomerulopathy was made.
Diagnosing fibronectin glomerulopathy could be challenging in many developing nations due to a lack of proper pathological and genetic testing infrastructure. Improving local health infrastructure for kidney tissue diagnosis could improve diagnostic accuracy, better guide management, and help avoid the administration of unnecessary medications with a potential for serious adverse events.
纤维连接蛋白肾小球病是一种罕见的常染色体显性疾病,其特征是肾脏内纤维连接蛋白异常沉积。它与FN1基因的几种变异突变有关。该疾病主要特征为蛋白尿,可达到肾病范围,主要在亚洲和白种人群中被描述。在此,我们报告一例来自埃塞俄比亚的纤维连接蛋白肾小球病病例,据我们所知,这是非洲首次报道的病例。
一名17岁的埃塞俄比亚女性出现全身肿胀和肾病范围蛋白尿。排除了肾病综合征的继发原因,但由于经济限制,未早期进行肾活检。患者最初接受肾素 - 血管紧张素系统抑制剂(RASi)和利尿剂治疗,随后使用类固醇和他克莫司,但未见明显反应。最终,在印度的一家病理实验室进行的肾活检和检查显示,有广泛的过碘酸希夫染色阳性但琼斯甲胺银染色阴性和刚果红染色阴性的系膜和毛细血管壁沉积物,免疫组化显示纤维连接蛋白染色强烈。确诊为纤维连接蛋白肾小球病。
由于缺乏适当的病理和基因检测基础设施,在许多发展中国家诊断纤维连接蛋白肾小球病可能具有挑战性。改善用于肾脏组织诊断的当地卫生基础设施可以提高诊断准确性,更好地指导治疗,并有助于避免使用可能导致严重不良事件的不必要药物。